Supercapsular percutaneously assisted total hip arthroplasty for osteoarthritis

Recommendation ID: IPG726/01
Question: Evidence on the safety and efficacy of supercapsular percutaneously assisted total hip arthroplasty for osteoarthritis is limited in quality and quantity. Therefore, this procedure should only be used with special arrangements for clinical governance, consent, and audit or research. Find out what special arrangements mean on the NICE interventional procedures guidance page.
Any explanatory notes (if applicable): Further research should include suitably powered randomised controlled trials comparing this procedure with standard approaches to total hip arthroplasty. It should report details of patient selection, short-term outcomes and long-term outcomes.

Source guidance details

Comes from guidance: Supercapsular percutaneously assisted total hip arthroplasty for osteoarthritis
Number: IPG726
Date issued: May 2022

Is this a recommendation for the use of a technology only in the context of research?	No
Is it a recommendation that suggests collection of data or the establishment of a register?	No
Last Reviewed	31/05/2022